قالب وردپرس درنا توس
Home / Tag Archives: Amgen

Tag Archives: Amgen

Amgen (AMGN) Announces FDA Approval for Migraine Treatment Aimovig

Enter StreetInsider Premium on Wall Street. Claim Your 2-Week Free Trial Here! Late Thursday, Amgen (NASDAQ: AMGN) announced that the FDA approved Aimovig for the preventative treatment of migraine in adults. Aimovig is a novel therapeutic approach that was developed as the first and only FDA-approved treatment for the prevention of migraine by blocking the receptor for cephalone gene-associated peptides …

Read More »

Express Scripts targets Amgen, Lilly migraine drugs in price development

LOS ANGELES (Reuters) – The largest US prescription manager tells drug manufacturers that the current pricing model is broken and Amgen Inc., Eli Lilly and Co. and other migraine drug manufacturers are trying to fix it. FILE PHOTO: An Amgen Sign is seen at the company's office in South San Francisco, California, USA, October 21, 2013. REUTERS / Robert Galbraith …

Read More »

Humira by AbbVie receives Biosim pardon – and Amgen gains imitator advantage – in the patent business with Samsung Bioepis

In a big win for AbbVie and its best selling drug – which is also the largest drug in the world – the company achieved another Humira biosimilars agreement that makes it "increasingly unlikely" that imitators were introduced to the US before 2023 But in Europe the threat will come much sooner. Following a similar deal with Amgen last year, …

Read More »